Latest News and Press Releases

Waltham, MA, June 13, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc. announced that it has achieved ISO 13485:2016 certification for their Munich location, upgraded from the ISO 13485:2003...

Waltham, MA, May 22, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc. announced today completion of its pre-clinical validation of a urine-based, gene expression panel intended for use as a...

Waltham, MA, May 17, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics’ novel urine-based prostate cancer liquid biopsy biomarker test, ExoDx™ Prostate(IntelliScore) or EPI, was selected out of 3000...

Waltham, MA, May 15, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc. received great interest from their presentations at the International Society for Extracellular Vesicles (ISEV) 2018 in...

Waltham, MA, May 09, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc. has continued to make significant progress in expanding contracts to provide laboratory services and ExoDx®...

Waltham, MA, May 08, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc. has expanded its urology salesforce within the United States after a successful first quarter commercial launch of ExoDx...

Waltham, MA, April 17, 2018 (GLOBE NEWSWIRE) -- This groundbreaking observation is presented as Late Breaking Research at the AACR Annual Meeting in Chicago on Tuesday by Dr Sudipto Chakrabortty....

Waltham, MA, March 21, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc., is thrilled to announce the appointment of Dr. Grannum Sant as Head of Medical Affairs.  As an internationally recognized...

Waltham, MA, March 20, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, recently published a study on the detection of the...

Boston, MA, March 14, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc., a market leader in liquid biopsy and the world’s first exosome-based diagnostics company announces a collaboration...